Clinical Trials

Status
Published

1464 Results

Active Filters

    Status Trial Number Title Sort descending Activated Closed Accrual Phase Published
    Closed SWOG-8090 A Descriptive Study of Chemotherapy Drug Extravasation and Treatments Commonly Instituted Among the Southwest Oncology Group 10/22/1980
    AP
    Closed SWOG-9031 A Double Blind Placebo Controlled Trial of Daunomycin and Cytosine Arabinoside With or Without rhG-CSF in Elderly Patients With Acute Myeloid Leukemia 11/15/1991 1/15/1995 100%
    III
    Published
    Closed S9617 A Phase I Study of PSC833 As Chemotherapy – Resistance Modifier in Patients Over Age 55 With Previously Untreated Myeloid Leukemia (AML). 11/1/1996 9/1/1998 100%
    I
    Published
    Closed SWOG-9112 A Phase I Study of the Combination of High Dose Chemotherapy, Granulocytemacrophage Colony Stimulating Factor, and Interleukin-2 7/15/1991 11/1/1992 3%
    I
    Closed SWOG-8940 A Phase I Study of the Combination of Recombinant Human Interleukin 1-Beta, Etoposide, and Carboplatin in Patients with Metastatic Cancer 3/1/1990 11/1/1992 100%
    I
    Published
    Closed SWOG-9462 (NABTC-9404) (NCI T94-0034) A Phase I Trial and Pharmacokinetic Study of the Sequential Administration of Carmustine (BCNU) and Temozolomide in Patients with CNS or Systemic Tumors Refractory to Standard Therapy 7/28/1995 8/15/1997 90%
    Closed NABTC-9702 (T96-0103) A Phase I Trial of Pre-Surgical O6-Benzylguanine in the Treatment of Patients with Malignant Glioma 4/1/1997 5/5/1997 Published
    Closed SWOG-9026 A Phase I, Open Label, Multicenter Study of the Safety, Tolerability and Biological Effects of SDZ ILE 964 (Recombinant Human Interleukin-3), Administered to Patients with Metastatic Cancer Prior to… 7/15/1991 9/29/1992 100%
    I
    Published
    Closed SWOG-9436 (NABTC-9403) (NCI T94-0184) A Phase I/II Trial of Paclitaxel (Taxol®) Chemotherapy for Recurrent Malignant Glioma 4/18/1995 2/4/1998 95%
    I-II
    Published
    Closed SWOG-9006 A Phase II 19F Magnetic Resonance Spectroscopy (MRS) Study of 5-FU and Correlation with Clinical Results of 5-FU/Leucovorin (LV) Therapy in Patients with Carcinomas of the Gastrointestinal Tract 10/15/1990 11/1/1996 77% Published
    Closed SWOG-9213 A Phase II Evaluation of Fazarabine for Patients with "Poor Prognosis” Extensive Stage Small Cell Lung Cancer 6/15/1993 6/15/1994 10%
    II
    Closed SWOG-9246 A Phase II Evaluation of Taxol in Patients with Relapsed Non-Hodgkin's Lymphoma 3/1/1993 12/1/1995 58%
    II
    Published
    Closed SWOG-9433 (CALGB-9331) A Phase II Feasibility Study of High Dose Cyclophosphamide, Cisplatin and Carmustine (CBP) Therapy as Consolidation for Patients with Limited Small Cell Lung Cancer (SCLC) in or Near Complete… 12/15/1994 3/31/1997
    II
    Closed SWOG-8900 A Phase II Pilot of VAD and VAD/Verapamil for Refractory Multiple Myeloma 5/1/1989 12/1/1991 100%
    II
    Published
    Closed SWOG-9107 A Phase II Pilot Study of High Dose 24-Hour Continuous Infusion 5-FU and Leucovorin and Low-Dose PALA for Patients with Colorectal Cancer 1/1/1993 8/1/1994 70%
    II
    Published
    Closed SWOG-9100 A Phase II Pilot Study of High-Dose 24 Hour Continuous Infusion 5-FU and Leucovorin and Low-Dose PALA in Patients with Pancreatic Adenocarcinoma 1/15/1993 8/1/1994 86% Published
    Closed SWOG-9403 (E3893) A Phase II Study of 13-cis Retinoic Acid plus Interferon a- 2a in Advanced Stage Penile Carcinoma. 3/1/1996 6/17/1998
    II
    Published
    Closed SWOG-9500 A Phase II Study of 7 + 3 and High Dose Ara-C Induction Therapy with Sequential High-Dose Ara-C Consolidation Therapy for Adults with De Novo Acute Myeloid Leukemia 12/15/1995 4/1/1997 100%
    II
    Published
    Closed SWOG-9143 A Phase II Study of Cisplatin Preceded by a 12-hour Continuous Infusion of Concurrent Hydroxyurea and Cytosine Arabinoside (Ara-C) for Patients with Untreated Malignant Mesothelioma 8/15/1992 9/15/1994 100%
    II
    Published
    Closed SWOG-9148 A Phase II Study of Cisplatin Preceded By A 12-Hour Continuous Infusion of Concurrent Hydroxyurea and Cytosine Arabinoside (Ara-C) For Patients with Untreated, Extensive Stage Small Cell and Non… 9/1/1992 6/1/1995 58%
    II
    Scroll Table